Education
About Us
Working with TipRanks
Follow Us
Peptidream Inc. (JP:4587)
:4587
4587 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥1,503.00 - ¥3,060.00
Previous CloseN/A
Volume553.80K
Average Volume (3M)792.04K
Market Cap
$199.41B
Enterprise Value¥198.19B
Total Cash (Recent Filing)$35.48B
Total Debt (Recent Filing)$19.37B
Price to Earnings (P/E)14.7
Beta1.02
Next Earnings
Nov 06, 2025EPS Estimate
32.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8.43
Shares Outstanding130,010,400
10 Day Avg. Volume1,102,700
30 Day Avg. Volume792,036
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.99
Enterprise Value/Revenue4.25
Enterprise Value/Gross Profit5.75
Enterprise Value/Ebitda8.49
Forecast
1Y Price Target
$1,888.66Price Target Upside19.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Peptidream News
4587 FAQ
What was Peptidream Inc.’s price range in the past 12 months?
Peptidream Inc. lowest stock price was ¥1503.00 and its highest was ¥3060.00 in the past 12 months.
What is Peptidream Inc.’s market cap?
Peptidream Inc.’s market cap is $199.41B.
When is Peptidream Inc.’s upcoming earnings report date?
Peptidream Inc.’s upcoming earnings report date is Nov 06, 2025 which is in 69 days.
How were Peptidream Inc.’s earnings last quarter?
Peptidream Inc. released its earnings results on Aug 07, 2025. The company reported -¥8.43 earnings per share for the quarter, missing the consensus estimate of ¥10.185 by -¥18.615.
Is Peptidream Inc. overvalued?
According to Wall Street analysts Peptidream Inc.’s price is currently Undervalued.
Does Peptidream Inc. pay dividends?
Peptidream Inc. does not currently pay dividends.
What is Peptidream Inc.’s EPS estimate?
Peptidream Inc.’s EPS estimate is 32.19.
How many shares outstanding does Peptidream Inc. have?
Peptidream Inc. has 130,010,400 shares outstanding.
What happened to Peptidream Inc.’s price movement after its last earnings report?
Peptidream Inc. reported an EPS of -¥8.43 in its last earnings report, missing expectations of ¥10.185. Following the earnings report the stock price went down -3.819%.
Which hedge fund is a major shareholder of Peptidream Inc.?
Currently, no hedge funds are holding shares in JP:4587
Company Description
Peptidream Inc.
PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform for the development of peptides. It has a collaborative research and exclusive license agreement with Takeda Pharmaceutical Company Limited to develop peptide drug conjugates for neuromuscular diseases. The company was incorporated in 2006 and is headquartered in Kawasaki, Japan.
4587 Company Deck
4587 Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a largely positive outlook for the company with strong financial performance and promising pipeline developments, despite some challenges in specific segments and uncertainties in deal closures.View all JP:4587 earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
2.64%
Mutual Funds
― Other Institutional Investors
93.77% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---